Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.
J A Koedam, … , J J Sixma, B N Bouma
J A Koedam, … , J J Sixma, B N Bouma
Published October 1, 1988
Citation Information: J Clin Invest. 1988;82(4):1236-1243. https://doi.org/10.1172/JCI113721.
View: Text | PDF
Research Article Article has an altmetric score of 6

Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor.

  • Text
  • PDF
Abstract

Activated protein C (APC) acts as a potent anticoagulant enzyme by inactivating Factor V and Factor VIII. In this study, protein S was shown to increase the inactivation of purified Factor VIII by APC ninefold. The reaction rate was saturated with respect to the concentration of protein S when protein S was present in a 10-fold molar excess over APC. The heavy chain of Factor VIII was cleaved by APC and protein S did not alter the degradation pattern. Factor VIII circulates in a complex with the adhesive protein von Willebrand factor. When purified Factor VIII was recombined with von Willebrand factor, the inactivation of Factor VIII by APC proceeded at a 10-20-fold slower rate as compared with Factor VIII in the absence of von Willebrand factor. Protein S had no effect on the inactivation of the Factor VIII-von Willebrand factor complex by APC. After treatment of this complex with thrombin, however, the actions of APC and protein S towards Factor VIII were completely restored. In hemophilia A plasma, purified Factor VIII associated with endogenous von Willebrand factor, resulting in a complete protection against APC (4 nM). By mixing hemophilic plasma with plasma from a patient with severe von Willebrand's disease, we could vary the amount of von Willebrand factor. 1 U of von Willebrand factor was needed to provide protection of 1 U Factor VIII. Also in plasma from patients with the IIA-type variant of von Willebrand's disease, Factor VIII was protected. In von Willebrand's disease plasma, which was depleted of protein S, APC did not inactivate Factor VIII. These results indicate that protein S serves as a cofactor in the inactivation of Factor VIII and Factor VIIIa by APC and that von Willebrand factor can regulate the action of these two anticoagulant proteins.

Authors

J A Koedam, J C Meijers, J J Sixma, B N Bouma

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1949 Total
Citations: 1 1 1 2 2 1 6 4 1 3 3 2 4 4 7 4 6 5 2 4 5 6 4 5 4 8 11 8 3 7 3 8 5 10 3 1 2 1 157
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (157)

Title and authors Publication Year
Complement or insult: the emerging link between complement cascade deficiencies and pathology of myeloid malignancies.
Oakes A, Liu Y, Dubielecka PM
Journal of leukocyte biology 2024
circ_0001274 competitively binds miR-143-3p to up-regulate VWF expression to improve acute traumatic coagulopathy
Yong Luo, Yong Fu, Ning Yang, Jian Zeng, Taifa Tan, Jun Hu, Fang Li, Liang Zeng, Wenchao Zhang, Zhanchen Liao, Zhigang Luo, Jian Peng
Oxidative medicine and cellular longevity 2023
Dysregulation of Protein S in COVID-19
Sim MM, Wood JP
Best practice & research. Clinical haematology 2022
Proteomics changes after negative pressure wound therapy in diabetic foot ulcers
Z Jia, L Liu, S Zhang, X Zhao, L Luo, Y Tang, B Shen, M Chen
Molecular medicine reports 2021
Acquired von Willebrand syndrome in patients with monoclonal gammopathy of undetermined significance investigated using a mechanistic approach.
Galletta E, Galvanin F, Bertomoro A, Daidone V, Casonato A
Blood transfusion = Trasfusione del sangue 2021
Pediatric Surgery: A Comprehensive Textbook for Africa
EA Ameh, SW Bickler, K Lakhoo, BC Nwomeh, D Poenaru
2020
FVIII/VWF complex displays a greater pro‐haemostatic activity than FVIII preparations devoid of VWF: Study in plasma and cell‐based models
CT Ammollo, F Semeraro, A Vitulli, L Dirienzo, AM Mezzasoma, N Semeraro, P Gresele, M Colucci
Haemophilia : the official journal of the World Federation of Hemophilia 2020
Genetic determinants of VWF clearance and FVIII binding modify FVIII pharmacokinetics in pediatric hemophilia A patients
LL Swystun, K Ogiwara, O Rawley, C Brown, I Georgescu, W Hopman, V Labarque, C Male, K Thom, VS Blanchette, MD Carcao, D Lillicrap
Blood 2019
Von Willebrand factor and ADAMTS13 activity in relation to risk of dementia: a population-based study
FJ Wolters, J Boender, PS de Vries, MA Sonneveld, PJ Koudstaal, MP de Maat, OH Franco, MK Ikram, FW Leebeek, MA Ikram
Scientific Reports 2018
An intronic mutation c.6430-3C>G in the F8 gene causes splicing efficiency and premature termination in hemophilia A:
Z Xia, J Lin, L Lu, C Kim, P Yu, M Qi
Blood Coagulation & Fibrinolysis 2018
Application of multiplexed ion mobility spectrometry towards the identification of host protein signatures of treatment effect in pulmonary tuberculosis
K Kedia, JP Wendler, ES Baker, KE Burnum-Johnson, LG Jarsberg, KG Stratton, AT Wright, PD Piehowski, MA Gritsenko, DM Lewinsohn, GB Sigal, MH Weiner, RD Smith, JM Jacobs, P Nahid
Tuberculosis (Edinburgh, Scotland) 2018
Immune Hematology
JM Despotovic
2018
Hematology - Latest Research and Clinical Advances
M Guenova, G Balatzenko
2018
A factor VIII–nanobody fusion protein forming an ultrastable complex with VWF: effect on clearance and antibody formation
V Muczynski, C Casari, F Moreau, G Aymé, C Kawecki, P Legendre, V Proulle, OD Christophe, CV Denis, PJ Lenting
Blood 2018
Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice
LL Swystun, I Georgescu, J Mewburn, M Deforest, K Nesbitt, K Hebert, C Dwyer, C Brown, C Notley, D Lillicrap
Journal of Thrombosis and Haemostasis 2017
Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis
TT Jiang, LY Shi, LL Wei, X Li, S Yang, C Wang, CM Liu, ZL Chen, HH Tu, ZJ Li, JC Li, S Kumar
PloS one 2017
Type 2N von Willebrand disease: Characterization and diagnostic difficulties
A Casonato, E Galletta, L Sarolo, V Daidone
Haemophilia : the official journal of the World Federation of Hemophilia 2017
THE COAGULATION FACTOR VIII: STRUCTURE AND APPLICATION
N Shurko, T Danysh, V Novak
2017
Amino-Terminal Fusion of Epidermal Growth Factor 4,5,6 Domains of Human Thrombomodulin on Streptokinase Confers Anti-Reocclusion Characteristics along with Plasmin-Mediated Clot Specificity
N Maheshwari, S Kantipudi, A Maheshwari, K Arora, Vandana, N Kwatra, G Sahni, A Bouchama
PloS one 2016
FcRn Rescues Recombinant Factor VIII Fc Fusion Protein from a VWF Independent FVIII Clearance Pathway in Mouse Hepatocytes
A der Flier, Z Liu, S Tan, K Chen, D Drager, T Liu, S Patarroyo-White, H Jiang, DR Light, CB Doering
PloS one 2015
Attenuating a sickle cell crisis with annexin V
JR Kennedy
Medical Hypotheses 2015
Thrombin generation and other coagulation parameters in a patient with homozygous congenital protein S deficiency on treatment with rivaroxaban
A Tripodi, I Martinelli, V Chantarangkul, M Clerici, A Artoni, S Passamonti, F Peyvandi
International Journal of Hematology 2015
An update on type 2B von Willebrand disease
S Mikhail, ES Aldin, M Streiff, A Zeidan
Expert Review of Hematology 2014
Changes in haemostatic parameters during the menstrual cycle and subsequent use of drospirenone-containing oral contraceptives
SN Tchaikovski, MC Thomassen, SD Costa, K Bremme, J Rosing
Thrombosis Research 2014
Novel factor V mutation (W1920R, FV Nara) associated with serious deep vein thrombosis and APC resistance : The plot thickens
K SHINOZAWA, K NOGAMI
Japanese Journal of Thrombosis and Hemostasis 2014
Von Willebrand Disease: Range of the Disease, and Management
KS Fernández, PA Alarcón
Current Pediatrics Reports 2013
Blood Clotting Factor VIII: From Evolution to Therapy
NA Orlova, SV Kovnir, II Vorobiev, AG Gabibov, AI Vorobiev
Acta Naturae 2013
Phenotypic implications of a co-existent haemorrhagic and thrombotic genotype :
J Thachil, V Martlew
Blood Coagulation & Fibrinolysis 2012
Management of bleeding disorders: basic science : BASIC SCIENCE OF BLEEDING DISORDERS MANAGEMENT
FA Ofosu, E Santagostino, S Grancha, P Marco
Haemophilia 2012
Thrombosis in VonWillebrand disease
W Qureshi, S Hassan, V Dabak, P Kuriakose
Thrombosis Research 2012
The fraction of recombinant factor VIII:Ag unable to bind von Willebrand factor has no FVIII coagulant activity: studies in vitro
FA Ofosu, H Tse, A Naqvi, H Bhakta, Y Song
Haemophilia 2012
Von Willebrand Disease
PM Mannucci, M Franchini
Von Willebrand Disease 2011
Advances in Clinical Chemistry
M Mahler
Advances in Clinical Chemistry Volume 54 2011
Clinical efficacy of a novel VWF-containing FVIII concentrate, Wilate®, in the prophylaxis and treatment of bleeding episodes in previously treated haemophilia A patients
A Klukowska, J Windyga, A Batorova
Thrombosis Research 2011
Role of protein S and tissue factor pathway inhibitor in the development of activated protein C resistance early in pregnancy in women with a history of preeclampsia :
SN Tchaikovski, MC Thomassen, SD Costa, LL Peeters, J Rosing
Thrombosis and Haemostasis 2011
Activated factor V is a cofactor for the activation of factor XI by thrombin in plasma
C Maas, JC Meijers, JA Marquart, K Bakhtiari, C Weeterings, PG de Groot, RT Urbanus
Proceedings of the National Academy of Sciences 2010
Porcine and Canine von Willebrand Factor and von Willebrand Disease: Hemostasis, Thrombosis, and Atherosclerosis Studies
TC Nichols, DA Bellinger, EP Merricks, RA Raymer, MT Kloos, N Defriess, MV Ragni, TR Griggs
Thrombosis 2010
Factor VIII and von Willebrand factor interaction: biological, clinical and therapeutic importance
V Terraube, JS O’donnell, PV Jenkins
Haemophilia 2010
C4BPB/C4BPA is a new susceptibility locus for venous thrombosis with unknown protein S-independent mechanism: results from genome-wide association and gene expression analyses followed by case-control studies
A Buil, DA Trégouët, JC Souto, N Saut, M Germain, M Rotival, L Tiret, F Cambien, M Lathrop, T Zeller, MC Alessi, SR de Cordoba, T Münzel, P Wild, J Fontcuberta, F Gagnon, J Emmerich, L Almasy, S Blankenberg, JM Soria, PE Morange
Blood 2010
Thrombin generation-based assays to measure the activity of the TFPI-protein S pathway in plasma from normal and protein S-deficient individuals
LF Maurissen, E Castoldi, P Simioni, J Rosing, TM Hackeng
Journal of Thrombosis and Haemostasis 2010
Effects of endothelin-1 and phenylephrine on plasma levels of von Willebrand factor and protein S
GC Leitner, L Schmetterer, S Kapiotis, B Jilma
Thrombosis Research 2010
Characterization of factor VIII pharmaceutical preparations by means of MudPIT proteomic approach
F Basilico, I Nardini, F Mori, E Brambilla, L Benazzi, AD Palma, E Rosti, C Farina, PL Mauri
Journal of Pharmaceutical and Biomedical Analysis 2010
Storage and regulated secretion of factor VIII in blood outgrowth endothelial cells
M Biggelaar, EA Bouwens, NA Kootstra, RP Hebbel, J Voorberg, K Mertens
Haematologica 2009
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency
TC Nichols, AM Dillow, HW Franck, EP Merricks, RA Raymer, DA Bellinger, VR Arruda, KA High
ILAR journal / National Research Council, Institute of Laboratory Animal Resources 2009
Factor VIII contributes to platelet-fibrin thrombus formation via thrombin generation under low shear conditions
C Sugita, A Yamashita, S Moriguchi-Goto, E Furukoji, M Takahashi, A Harada, T Soeda, T Kitazawa, K Hattori, S Tamura, Y Asada
Thrombosis Research 2009
Pregnancy-associated changes in the hemostatic system in wild-type and factor V Leiden mice
SN Tchaikovski, BJ van Vlijmen, AC Cleuren, MC Thomassen, V Tchaikovski, G Tans, J Rosing
Journal of Thrombosis and Haemostasis 2009
Dynamics of factor VIII interactions determine its immunologic fate in hemophilia A
S Lacroix-Desmazes, AM Navarrete, S Andre, J Bayry, SV Kaveri, S Dasgupta
Blood 2008
The disappearing act of factor VIII
PJ Lenting, OD Christophe, P Guéguen
Haemophilia 2008
Macrophages contribute to the cellular uptake of von Willebrand factor and factor VIII in vivo
CJ van Schooten, S Shahbazi, E Groot, BD Oortwijn, HM van Berg, CV Denis, PJ Lenting
Blood 2008
Re-evaluation of the role of the protein S-C4b binding protein complex in activated protein C-catalyzed factor Va-inactivation
LF Maurissen, MC Thomassen, GA Nicolaes, B Dahlback, G Tans, J Rosing, TM Hackeng
Blood 2008
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate®P/ Humate®-P: History and clinical performance
E Berntorp, W Archey, G Auerswald, AB Federici, M Franchini, S Knaub, W Kreuz, S Lethagen, PM Mannucci, H Pollmann, I Scharrer, K Hoots
European Journal of Haematology 2008
Detailed Mechanisms of the Inactivation of Factor VIIIa by Activated Protein C in the Presence of Its Cofactors, Protein S and Factor V
AJ Gale, TJ Cramer, D Rozenshteyn, JR Cruz
The Journal of biological chemistry 2008
Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors
BM Reipert, PM van Helden, HP Schwarz, C Hausl
British Journal of Haematology 2007
Multiple congenital coagulopathies co-expressed with Von Willebrand’s disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature
E Asatiani, CM Kessler
Haemophilia 2007
Spectrum of molecular defects and mutation detection rate in patients with mild and moderate hemophilia A
N Bogdanova, A Markoff, R Eisert, C Wermes, H Pollmann, A Todorova, M Chlystun, U Nowak-Göttl, J Horst
Human Mutation 2007
Nonhemophilic Inhibitors of Coagulation
BM Ewenstein
Consultative Hemostasis and Thrombosis 2007
Consultative Hemostasis and Thrombosis
VJ Marder
Consultative Hemostasis and Thrombosis 2007
Protein S Multimers Are Generated In Vitro and Affect Protein S Structure-Function Analyses
KM Seré, GM Willems, J Rosing, TM Hackeng
Seminars in Hematology 2006
Characterization of Factor VIII Inhibitors
M Shima
International Journal of Hematology 2006
Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count
T Lisman, J Adelmeijer, S Cauwenberghs, EC van Pampus, JW Heemskerk, PG de Groot
Journal of Thrombosis and Haemostasis 2005
Comparative Measurement of Anti-Factor VIII Antibody by Bethesda Assay and ELISA Reveals Restricted Isotype Profile and Epitope Specificity
F Towfighi, S Gharagozlou, RA Sharifian, A Kazemnejad, K Esmailzadeh, MR Managhchi, F Shokri
Acta Haematologica 2005
Lack of desmopressin (DDAVP) response in men with hemophilia A following liver transplantation
PA Lamont, MV Ragni
Journal of Thrombosis and Haemostasis 2005
Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions
K Tomokiyo, Y Kamikubo, T Hanada, T Araki, Y Nakatomi, Y Ogata, SM Jung, T Nakagaki, M Moroi
Blood 2005
Successful treatment for patients with von Willebrand disease undergoing urgent surgery using factor VIII/VWF concentrate (Humate-PR)
AR Thompson, JC Gill, BM Ewenstein, G Mueller-Velten, BA Schwartz
Haemophilia 2004
Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates
Y Lin, X Yang, MC Chevrier, S Craven, TW Barrowcliffe, R Lemieux, FA Ofosu
Haemophilia 2004
Direct anticoagulant activity of protein S-C4b binding protein complex in Heerlen heterozygotes and normals*
MJ Heeb, RR Koenen, JA Fernandez, TM Hackeng
Journal of Thrombosis and Haemostasis 2004
Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance
KM Seré, J Rosing, TM Hackeng
Blood 2004
Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation
T Lisman, J Adelmeijer, HF Heijnen, PG de Groot
Blood 2004
Cellular mechanisms of the hemostatic effects of desmopressin (DDAVP)
JE Kaufmann, UM Vischer
Journal of Thrombosis and Haemostasis 2003
A study on associations between antiprothrombin antibodies, antiplasminogen antibodies and thrombosis
MJ Simmelink, PG de Groot, RH Derksen
Journal of Thrombosis and Haemostasis 2003
Successful treatment of urgent bleeding in von Willebrand disease with factor VIII/VWF concentrate (Humate-PR): use of the ristocetin cofactor assay (VWF:RCo) to measure potency and to guide therapy
JC Gill, BM Ewenstein, AR Thompson, G Mueller-Velten, BA Schwartz
Haemophilia 2003
Recombinant factor VIIa enhances deposition of platelets with congenital or acquired αIIbβ3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor–independent thrombin generation
T Lisman, S Moschatsis, J Adelmeijer, HK Nieuwenhuis, PG Groot
Blood 2003
The APC-independent anticoagulant activity of protein S in plasma is decreased by elevated prothrombin levels due to the prothrombin G20210A mutation
RR Koenen, G Tans, R van Oerle, K Hamulyák, J Rosing, TM Hackeng
Blood 2003
Genetic determinants of variation in the plasma levels of the C4b-binding protein (C4BP) in Spanish families
J Esparza-Gordillo, JM Soria, A Buil, JC Souto, L Almasy, J Blangero, J Fontcuberta, SR de Córdoba
Immunogenetics 2003
Low levels of activated protein C in patients with systemic lupus erythematosus do not relate to lupus anticoagulants but to low levels of factor II
MJ Simmelink, JA Fernandez, RH Derksen, JH Griffin, PG de Groot
British Journal of Haematology 2002
Activated Protein C-Dependent and –Independent Anticoagulant Activities of Protein S Have Different Structural Requirements
MJ Heeb, JH Griffin
Blood Cells, Molecules, and Diseases 2002
Structural Requirements of Anticoagulant Protein S for Its Binding to the Complement Regulator C4b-binding Protein
TK Giri, S Linse, PG de Frutos, T Yamazaki, BO Villoutreix, B Dahlbäck
The Journal of biological chemistry 2002
Pan Vascular Medicine
P Lanzer, EJ Topol
2002
Complexes of anti-prothrombin antibodies and prothrombin cause lupus anticoagulant activity by competing with the binding of clotting factors for catalytic phospholipid surfaces
MJ Simmelink, DA Horbach, RH Derksen, JC Meijers, EM Bevers, GM Willems, PG de Groot
British Journal of Haematology 2001
The molecular biology of von Willebrand disease
S Keeney, AM Cumming
Clinical and Laboratory Haematology 2001
Type 2N von Willebrand disease: clinical manifestations, pathophysiology, laboratory diagnosis and molecular biology
C Mazurier, J Goudemand, L Hilbert, C Caron, E Fressinaud, D Meyer
Best Practice & Research Clinical Haematology 2001
Circulating factor VIII immune complexes in patients with type 2 acquired hemophilia A and protection from activated protein C–mediated proteolysis
K Nogami, M Shima, JC Giddings, K Hosokawa, M Nagata, S Kamisue, H Suzuki, M Shibata, EL Saenko, I Tanaka, A Yoshioka
Blood 2001
Purified Protein S Contains Multimeric Forms with Increased APC-Independent Anticoagulant Activity
KM Seré, MP Janssen, GM Willems, G Tans, J Rosing, TM Hackeng
Biochemistry 2001
HEMORRHAGIC PROBLEMS IN OBSTETRICS, EXCLUSIVE OF DISSEMINATED INTRAVASCULAR COAGULATION
FA Nizzi, G Mues
Hematology/Oncology Clinics of North America 2000
Involvement of low-density lipoprotein receptor-related protein (LRP) in the clearance of factor VIII in von Willebrand factor–deficient mice
HP Schwarz, PJ Lenting, B Binder, J Mihaly, C Denis, F Dorner, PL Turecek
Blood 2000
A novel cause of mild/moderate hemophilia A: mutations scattered in the factor VIII C1 domain reduce factor VIII binding to von Willebrand factor
M Jacquemin, R Lavend'homme, A Benhida, B Vanzieleghem, R d'Oiron, JM Lavergne, HH Brackmann, R Schwaab, T VandenDriessche, MK Chuah, M Hoylaerts, JG Gilles, K Peerlinck, J Vermylen, JM Saint-Remy
Blood 2000
Self-Association of Human Protein S
JE Pauls, MF Hockin, GL Long, KG Mann
Biochemistry 2000
High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C
JH Griffin, K Kojima, CL Banka, LK Curtiss, JA Fernández
Journal of Clinical Investigation 1999
C4b-Binding Protein (C4BP) β-Chain Short Consensus Repeat-2 Specifically Contributes to the Interaction of C4BP with Protein S
RH van de Poel, JC Meijers, B Dahlbäck, BN Bouma
Blood Cells, Molecules, and Diseases 1999
Gas6, a ligand for the receptor protein-tyrosine kinase Tyro-3, is widely expressed in the central nervous system
AL Prieto, JL Weber, S Tracy, MJ Heeb, C Lai
Brain Research 1999
Catalytic activity of antibodies against factor VIII in patients with hemophilia A
S Lacroix-Desmazes, A Moreau, Sooryanarayana, C Bonnemain, N Stieltjes, A Pashov, Y Sultan, J Hoebeke, MD Kazatchkine, SV Kaveri
Nature Medicine 1999
Interaction between Protein S and Complement C4b-binding Protein (C4BP): AFFINITY STUDIES USING CHIMERAS CONTAINING C4BP β-CHAIN SHORT CONSENSUS REPEATS
RH van de Poel, JC Meijers, BN Bouma
The Journal of biological chemistry 1999
Antithrombotics
AC Uprichard, KP Gallagher
1999
Laboratory Techniques in Thrombosis - a Manual
J Jespersen, RM Bertina, F Haverkate
1999
Activated Platelets Release Two Types of Membrane Vesicles: Microvesicles by Surface Shedding and Exosomes Derived From Exocytosis of Multivesicular Bodies and -Granules
HF Heijnen, AE Schiel, R Fijnheer, HJ Geuze, JJ Sixma
Blood 1999
Can we improve on nature? "Super molecules" of factor VIII
RJ Kaufman, SW Pipe
Haemophilia 1998
Summary of a workshop on potency and dosage of von Willebrand factor concentrates
Chang, Rick, L. Ross Pierce, Weinstein
Haemophilia 1998
Pharmacokinetics, efficacy and safety of Humate-P®in von Willebrand disease
Dobrkovska, Krzensk, Chediak
Haemophilia 1998
Characterization of mini-protein S, a recombinant variant of protein S that lacks the sex hormone binding globulin-like domain
MV Wijnen, JG Stam, GT Chang, JC Meijers, PH Reitsma, RM Bertina, BN Bouma
Biochemical Journal 1998
Involvement of Amino Acid Residues 423–429 of Human Protein S in Binding to C4b-Binding Protein
JA Fernández, JH Griffin, GT Chang, J Stam, PH Reitsma, RM Bertina, BN Bouma
Blood Cells, Molecules, and Diseases 1998
Chemical synthesis of human protein S thrombin-sensitive module and first epidermal growth factor module
TM Hackeng, PE Dawson, SB Kent, JH Griffin
Biopolymers 1998
The Role of Platelet Von Willebrand Factor in the Binding of Factor VIII to Activated Platelets
H Suzuki, M Shima, S Kamisue, H Nakai, K Nogami, M Shibata, S Morichika, I Tanaka, JC Giddings, A Yoshioka
Thrombosis Research 1998
The Life Cycle of Coagulation Factor VIII in View of Its Structure and Function
PJ Lenting, JA van Mourik, K Mertens
Blood 1998
The Structure and Function of Murine Factor V and Its Inactivation by Protein C
TL Yang, J Cui, A Rehumtulla, A Yang, M Moussalli, RJ Kaufman, D Ginsburg
Blood 1998
A Novel Mutation in the D3 Domain of von Willebrand Factor Markedly Decreases Its Ability to Bind Factor VIII and Affects Its Multimerization
S Jorieux, C Gaucher, J Goudemand, C Mazurier
Blood 1998
Physiology of the Acute Wound
WT Lawrence
Clinics in Plastic Surgery 1998
von Willebrand Disease
WC Nichols, D Ginsburg
Medicine 1997
Transgenic pigs produce functional human factor VIII in milk
RK Paleyanda, WH Velander, TK Lee, DH Scandella, FC Gwazdauskas, JW Knight, LW Hoyer, WN Drohan, H Lubon
Nature Biotechnology 1997
von Willebrand Disease:
WC Nichols, D Ginsburg
Medicine 1997
Intrinsic Anticoagulation: Protein C, Protein S, and Thrombomodulin
JL Hale, N Nathan, M D'Ambra
Seminars in cardiothoracic and vascular anesthesia 1997
Inhibitory Mechanism of the Protein C Pathway on Tissue Factor-induced Thrombin Generation: SYNERGISTIC EFFECT IN COMBINATION WITH TISSUE FACTOR PATHWAY INHIBITOR
C Veer, NJ Golden, M Kalafatis, KG Mann
The Journal of biological chemistry 1997
Increased Tissue Factor-initiated Prothrombin Activation as a Result of the Arg 506 → Gln Mutation in Factor V LEIDEN
C Veer, M Kalafatis, RM Bertina, P Simioni, KG Mann
The Journal of biological chemistry 1997
26. Hämophilie-Symposion 1995
I Scharrer, W Schramm
1997
An In Vitro Analysis of the Combination of Hemophilia A and Factor VLEIDEN
C van t Veer, NJ Golden, M Kalafatis, P Simioni, RM Bertina, KG Mann
Blood 1997
Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII
ME Rick, DM Krizek
American Journal of Hematology 1996
Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin
TM Hackeng, G Tans, SJ Koppelman, PG de Groot, J Rosing, BN Bouma
Biochemical Journal 1996
Factor VIII C2 Domain Missense Mutations Exhibit Defective Trafficking of Biologically Functional Proteins
SW Pipe, RJ Kaufman
The Journal of biological chemistry 1996
Pathogenesis, Clinical Picture and Treatment of von Willebrand's Disease
SR Lethagen
Annals of Medicine 1995
Expression and Functional Characterization of Chimeras Between Human and Bovine Vitamin-K-dependent Protein-S-defining Modules Important for the Species Specificity of the Activated Protein C Cofactor Activity
X He, L Shen, B Dahlback
European Journal of Biochemistry 1995
Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras
TC Nichols, CM Samama, DA Bellinger, J Roussi, RL Reddick, M Bonneau, MS Read, O Bailliart, GG Koch, M Vaiman
Proceedings of the National Academy of Sciences 1995
Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry
J Spaargaren, PL Giesen, MP Janssen, J Voorberg, GM Willems, JA van Mourik
Biochemical Journal 1995
Cofactors V and VIII after endotoxin administration to human volunteers
EG Wyshock, AF Suffredini, JE Parrillo, RW Colman
Thrombosis Research 1995
Inhibitors to Coagulation Factors
LM Aledort, LW Hoyer, JM Lusher, HM Reisner, GC White
1995
Hereditary Diseases and Blood Transfusion
CT Sibinga, PC Das, E Briët
1995
Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa
TM Hackeng, , JC Meijers, BN Bouma
The Journal of biological chemistry 1994
The mechanism of inactivation of human factor V and human factor Va by activated protein C
M Kalafatis, MD Rand, KG Mann
The Journal of biological chemistry 1994
Factor IXa protects factor VIIIa from activated protein C. Factor IXa inhibits activated protein C-catalyzed cleavage of factor VIIIa at Arg562
LM Regan, BJ Lamphear, CF Huggins, FJ Walker, PJ Fay
The Journal of biological chemistry 1994
von Willebrand's disease. Pathogenesis and clinical aspects
S Lethagen
Critical Reviews in Oncology/Hematology 1993
Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study
T Koster, JP Vandenbroucke, FR Rosendaal, H Ronde, E Briët, RM Bertina
The Lancet 1993
Detection of canine carriers of haemophilia A using factor VIII activity and von Willebrand factor antigen concentration
PD Mansell, BW Parry, GA Anderson
Preventive Veterinary Medicine 1993
Basics of Cutaneous Wound Repair
RA Clark
The Journal of Dermatologic Surgery and Oncology 1993
Factor VIII: Structure, function and analysis
M Fiona, ÓF Ciarán, OK Richard
Biotechnology Advances 1993
Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C
TM Hackeng, M Hessing, , F Meijer-Huizinga, JC Meijers, PG de Groot, JA van Mourik, BN Bouma
The Journal of biological chemistry 1993
High affinity binding of human vitamin K-dependent protein S to a truncated recombinant beta-chain of C4b-binding protein expressed in Escherichia coli
Y Härdig, A Rezaie, B Dahlbäck
The Journal of biological chemistry 1993
Autosomal recessive transmission of hemophilia A due to a von Willebrand factor mutation
RJ Wise, BM Ewenstein, J Gorlin, SC Narins, M Jesson, RI Handin
Human Genetics 1993
A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675–Glu1684inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells
M Shima, A Yoshioka, M Nakajima, H Nakai, H Fukui
British Journal of Haematology 1992
Further evidence for recessive inheritance of von willebrand disease with abnormal binding of von willebrand factor to factor VIII
MF Lopez-Fernandez, MJ Blanco-Lopez, MP Castiñeira, J Batlle
American Journal of Hematology 1992
Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely
S Layet, JP Girma, B Obert, E Peynaud-Debayle, N Bihoreau, D Meyer
Biochemical Journal 1992
Pharmacokinetics and hemostatic effect of different factor VIII/von Willebrand factor concentrates in von Willebrand's disease type III
S Lethagen, E Berntorp, IM Nilsson
Annals of Hematology 1992
ECAT Assay Procedures A Manual of Laboratory Techniques
J Jespersen, RM Bertina, F Haverkate
1992
Insight into the structure, function, and biosynthesis of factor VIII through recombinant DNA technology
RJ Kaufman
Annals of Hematology 1991
The interaction between complement component C4b-binding protein and the vitamin K-dependent protein S forms a link between blood coagulation and the complement system
M Hessing
Biochemical Journal 1991
Factor VIII Structure and Function
DN Fass
Annals of the New York Academy of Sciences 1991
Thrombin cleavage analysis of a novel antihaemophilic factor variant, factor VIII Delta II
S KRISHNAN, HV KOLBE, P LEPAGE, T FAURE, R SAUERWALD, H SALLE, C MULLER, N BIHOREAU, P PAOLANTONACCI, C ROITSCH, P MEULIEN, A PAVIRANI
European Journal of Biochemistry 1991
Structure-function studies on human C4b-binding protein using monoclonal antibodies
M Hessing, HF Heijnen, TM Hackeng, JJ Sixma, BN Bouma
European Journal of Immunology 1991
The Association of Factor VIII With von Willebrand Factor
P Lollar
Mayo Clinic Proceedings 1991
Recombinant Technology in Hemostasis and Thrombosis
LW Hoyer, WN Drohan
1991
The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets
M Nesheim, DD Pittman, AR Giles, DN Fass, JH Wang, D Slonosky, RJ Kaufman
The Journal of biological chemistry 1991
The role of von Willebrand factor multimers and propeptide cleavage in binding and stabilization of factor VIII
RJ Wise, AJ Dorner, M Krane, DD Pittman, RJ Kaufman
The Journal of biological chemistry 1991
von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation
PJ Fay, JV Coumans, FJ Walker
The Journal of biological chemistry 1991
Enhancement of rabbit protein S anticoagulant cofactor activity in vivo by modulation of the protein S C4B binding protein interaction
RE Weinstein, FJ Walker
Journal of Clinical Investigation 1990
The effect of von Willebrand factor on activation of factor VIII by factor Xa
JA KOEDAM, RJ HAMER, NH BEESER-VISSER, BN BOUMA, JJ SIXMA
European Journal of Biochemistry 1990
Characterization of human factor VIII and interaction with von Willebrand factor. An electron microscopic study
HF HEIJNEN, JA KOEDAM, H SANDBERG, NH BEESER-VISSER, JW SLOT, JJ SIXMA
European Journal of Biochemistry 1990
6 Von Willebrand factor and platelet function
D Baruch, B Bahnak, JP Girma, D Meyer
Baillière's Clinical Haematology 1989
An Overview of Hemostasis
GC Troy
Veterinary Clinics of North America Small Animal Practice 1988
The Molecular and Cellular Biology of Wound Repair
RA Clark, PM Henson
1988
Hematology
JJ Shea, JJ Shea
The Laryngoscope 1949

← Previous 1 2 3 … 6 7 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 7 patents
50 readers on Mendeley
See more details